Xi Venture Capital was awarded the top 20 most active investment institutions in the medical and health field by the First New Voice

　　In order to better evaluate the trading situation of the new economy equity investment market, First New Voice focuses on the investment, fundraising, and other aspects of the domestic new economy equity investment market in the second quarter of 2024 IPO、 Based on big data, service transactions and other data are collected through various methods such as survey questionnaires, telephone interviews, and institutional research. The data information is independently submitted by institutions, and LP executives serve as judges for investment institution related rankings to select the market's investment, fundraising IPO、 The most active institutions in service transactions and other related areas. Xi Venture Capital has been awarded the top 20 most active investment institutions in the healthcare sector for the second quarter of 2024.

　　Xi Venture Capital has currently established a specialized and diversified medical and health investment team, with layouts in innovative drugs, biotechnology, medical devices, and other fields. As of 2024, Xi Venture Capital has completed nearly 20 project investments in this field, including a group of high-quality enterprises such as Qirui, Jianshi, Shixi, Zhikang Hongyi, etc. In addition, Xi Venture Capital has established a joint venture with the Municipal Medical and Health Group, focusing on industrial investment funds and major project introductions. Through the operation mode of "park within park", high-quality high growth enterprises are attracted to continuously gather in major biopharmaceutical parks in Wuxi, achieving industrial development from "full chain" to "ecological excellence".